Effects of genistein and estrogen receptor subtype-specific agonists in ArKO mice following different administration routes

Molecular and Cellular Endocrinology

Volumn 314, Issue 1, 2010, Pages 41-52

  Bliedtner, Anja ^a   Zierau, Oliver ^a   Albrecht, Steffen ^b   Liebhaber, Steffi ^a   Vollmer, Günter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

ArKO mice; ER subtype selective ligands; Estrogen receptors; Genistein; Uterotrophic assay

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHINYLESTRADIOL; GENISTEIN; GONADOTROPIN; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE ACTION; HORMONE RESPONSE; HYPOPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERUS DISEASE; UTERUS WEIGHT;

EID: 70350202524     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.07.032     Document Type: Article

References (49)

1. Adashi E.Y., and Hsueh A.J. Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells. J. Biol. Chem. 257 (1982) 6077-6083
2. Britt K.L., Simpson E.R., and Findlay J.K. Effects of phytoestrogens on the ovarian and pituitary phenotypes of estrogen-deficient female aromatase knockout mice. Menopause 12 (2005) 174-185
3. Britt K.L., Stanton P.G., Misso M., Simpson E.R., and Findlay J.K. The effects of estrogen on the expression of genes underlying the differentiation of somatic cells in the murine gonad. Endocrinology 145 (2004) 3950-3960
4. Couse J.F., Hewitt S.C., Bunch D.O., Sar M., Walker V.R., Davis B.J., and Korach K.S. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 286 (1999) 2328-2331
5. Couse J.F., and Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 20 (1999) 358-417
6. Couse J.F., Yates M.M., Walker V.R., and Korach K.S. Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta. Mol. Endocrinol. 17 (2003) 1039-1053
7. Deroo B.J., Hewitt S.C., Peddada S.D., and Korach K.S. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus. Endocrinology 145 (2004) 5485-5492
8. Diel P., Geis R.B., Caldarelli A., Schmidt S., Leschowsky U.L., Voss A., and Vollmer G. The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression. Mol. Cell. Endocrinol. 221 (2004) 21-32
9. Diel P., Schmidt S., and Vollmer G. In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 777 (2002) 191-202
10. Diel P., Smolnikar K., Schulz T., Laudenbach-Leschowski U., Michna H., and Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum. Reprod. 16 (2001) 997-1006
11. Drummond A.E., Baillie A.J., and Findlay J.K. Ovarian estrogen receptor alpha and beta mRNA expression: impact of development and estrogen. Mol. Cell. Endocrinol. 149 (1999) 153-161
12. Drummond A.E., Britt K.L., Dyson M., Jones M.E., Kerr J.B., O'donnell L., Simpson E.R., and Findlay J.K. Ovarian steroid receptors and their role in ovarian function. Mol. Cell. Endocrinol. 191 (2002) 27-33
13. Eisenberg E., and Levanon E.Y. Human housekeeping genes are compact. Trends Genet. 19 (2003) 362-365
14. Fisher C.R., Graves K.H., Parlow A.F., and Simpson E.R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6965-6970
15. Frasor J., Barnett D.H., Danes J.M., Hess R., Parlow A.F., and Katzenellenbogen B.S. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 144 (2003) 3159-3166
16. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., and Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 (1986) 134-139
17. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., and Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 231 (1986) 1150-1154
18. Hagihara K., Wu-Peng X.S., Funabashi T., Kato J., and Pfaff D.W. Nucleic acid sequence and DNase hypersensitive sites of the 5′ region of the mouse progesterone receptor gene. Biochem. Biophys. Res. Commun. 205 (1994) 1093-1101
19. Hall J.M., and Mcdonnell D.P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 (1999) 5566-5578
20. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., and Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87 (2007) 905-931
21. Iida K., Imai A., and Tamaya T. Stimulatory effects of estrogen on gonadotropin-releasing hormone-induced phosphoinositide turnover in granulosa cells. J. Steroid Biochem. Mol. Biol. 38 (1991) 583-586
22. Inhoffen H.H., and Hohlweg W. Neue per os-wirksame weibliche Keimdrüsenhormon-Derivate: 17-Aethinyl-oestradiol und Pregnen-in-on-3-ol-17. Naturwissenschaften 109 (1938) 96
23. Kanno J., Onyon L., Haseman J., Fenner-Crisp P., Ashby J., and Owens W. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ. Health Perspect. 109 (2001) 785-794
24. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., Sar M., Korach K.S., Gustafsson J.A., and Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15677-15682
25. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
26. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5925-5930
27. Kurita T., Lee K., Saunders P.T., Cooke P.S., Taylor J.A., Lubahn D.B., Zhao C., Makela S., Gustafsson J.A., Dahiya R., and Cunha G.R. Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse. Biol. Reprod. 64 (2001) 272-283
28. Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., and Katzenellenbogen J.A. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J. Med. Chem. 44 (2001) 4230-4251
29. Möller F.J., Zierau O., Hertrampf T., Bliedtner A., Diel P., and Vollmer G. Long-term effects of dietary isoflavones on uterine gene expression profiles. J. Steroid Biochem. Mol. Biol. 113 (2009) 296-303
30. Mosselman S., Polman J., and Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392 (1996) 49-53
31. Nimrod A., Bedrak E., and Lamprecht S.A. Appearance of LH-receptors and LH-stimulable cyclic AMP accumulation in granulosa cells during follicular maturation in the rat ovary. Biochem. Biophys. Res. Commun. 78 (1977) 977-984
32. O'lone R., Frith M.C., Karlsson E.K., and Hansen U. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 18 (2004) 1859-1875
33. Odum J., Lefevre P.A., Tittensor S., Paton D., Routledge E.J., Beresford N.A., Sumpter J.P., and Ashby J. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul. Toxicol. Pharmacol. 25 (1997) 176-188
34. Pelletier G., and El-Alfy M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J. Clin. Endocrinol. Metab. 85 (2000) 4835-4840
35. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
36. Pillai S.B., Jones J.M., and Koos R.D. Treatment of rats with 17beta-estradiol or relaxin rapidly inhibits uterine estrogen receptor beta1 and beta2 messenger ribonucleic acid levels. Biol. Reprod. 67 (2002) 1919-1926
37. Richards J.S. Estradiol receptor content in rat granulosa cells during follicular development: modification by estradiol and gonadotropins. Endocrinology 97 (1975) 1174-1184
38. Rider V. Progesterone and the control of uterine cell proliferation and differentiation. Front. Biosci. 7 (2002) d1545-1555
39. Saarinen N.M., Bingham C., Lorenzetti S., Mortensen A., Makela S., Penttinen P., Sorensen I.K., Valsta L.M., Virgili F., Vollmer G., Warri A., and Zierau O. Tools to evaluate estrogenic potency of dietary phytoestrogens: a consensus paper from the EU Thematic Network "Phytohealth" (QLKI-2002-2453). Genes Nutr. 1 (2006) 143-158
40. Shi H., and Teng C. Promoter-specific activation of mouse lactoferrin gene by epidermal growth factor involves two adjacent regulatory elements. Mol. Endocrinol. 10 (1996) 732-741
41. Simpson E.R. Models of aromatase insufficiency. Semin. Reprod. Med. 22 (2004) 25-30
42. Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B.S., and Katzenellenbogen J.A. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J. Med. Chem. 43 (2000) 4934-4947
43. Teng C., Shi H., Yang N., and Shigeta H. Mouse lactoferrin gene. Promoter-specific regulation by EGF and cDNA cloning of the EGF-response-element binding protein. Adv. Exp. Med. Biol. 443 (1998) 65-78
44. Toda K., Hayashi Y., Okada T., Morohashi K., and Saibara T. Expression of the estrogen-inducible EGFP gene in aromatase-null mice reveals differential tissue responses to estrogenic compounds. Mol. Cell. Endocrinol. 229 (2005) 119-126
45. Toda K., Takeda K., Okada T., Akira S., Saibara T., Kaname T., Yamamura K., Onishi S., and Shizuta Y. Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. J. Endocrinol. 170 (2001) 99-111
46. Waters K.M., Safe S., and Gaido K.W. Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol. Sci. 63 (2001) 47-56
47. Weihua Z., Saji S., Makinen S., Cheng G., Jensen E.V., Warner M., and Gustafsson J.A. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5936-5941
48. Winer J., Jung C.K., Shackel I., and Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270 (1999) 41-49
49. Zierau O., Kretzschmar G., Moller F., Weigt C., and Vollmer G. Time dependency of uterine effects of naringenin type phytoestrogens in vivo. Mol. Cell. Endocrinol. 294 (2008) 92-99